focus trial semaglutide Four interesting trials studying semaglutide; #retinopathy FLOW #CKD SOUL #CVD and with tirzepatide coming, SUSTAIN FORTE a look at higher dose once weekly #diabetes A Critical Appraisal of the

The end result looks similar to recomposition in the mirror because you lose fat without losing the muscle definition underneath

Ruiz, A

Tirzepatide, a dual GLP-1/GIP agonist marketed as Zepbound and Mounjaro, pushed that even further with up to 22.5% weight reduction

[DOI] [PubMed] [Google Scholar] 4

Given below is the typical dosing schedule: Weeks 14 : 0.25 mg once weekly (initial dose) Weeks 58 : 0.5 mg once weekly Weeks 912 : 1 mg once weekly Weeks 1316 : 1.7 mg once weekly Week 17 and onward : 2.4 mg once weekly (maintenance dose for adults and pediatric patients aged 12 years and older) Each dose is administered subcutaneously using a prefilled injection pen